Drug Shortage Report for APO-DIVALPROEX

Last updated on 2022-05-13 History
Report ID 156990
Drug Identification Number 02239700
Brand name APO-DIVALPROEX
Common or Proper name DIVALPROEX
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) VALPROIC ACID
Strength(s) 500MG
Dosage form(s) TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED)
Route of administration ORAL ORAL
Packaging size 100 BTL
ATC code N03AG
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-03-15
Estimated end date 2022-06-03
Actual end date
Shortage status Actual shortage
Updated date 2022-05-13
Company comments Limited inventory is available
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2022-05-13 French Compare
v11 2022-05-13 English Compare
v10 2022-05-06 French Compare
v9 2022-05-06 English Compare
v8 2022-04-29 French Compare
v7 2022-04-29 English Compare
v6 2022-04-29 French Compare
v5 2022-04-29 English Compare
v4 2022-03-29 French Compare
v3 2022-03-29 English Compare
v2 2022-03-18 French Compare
v1 2022-03-18 English Compare

Showing 1 to 12 of 12